S. Jakobovits

发表

Characterization of Inflammatory Bowel Disease With Urinary Metabolic Profiling

D. Jewell, S. Taylor-Robinson, S. Marshall, 2009, The American Journal of Gastroenterology.

Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients – a POCER study analysis

M. Kamm, W. Selby, J. Andrews, 2015, Alimentary pharmacology & therapeutics.

OP023 Optimising post-operative Crohn's disease management: Best drug therapy alone versus endoscopic monitoring, disease evolution, and faecal calprotectin monitoring. The POCER study

M. Kamm, W. Selby, J. Andrews, 2014 .

Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease

P. Bampton, G. Radford-Smith, P. Pavli, 2018, European journal of gastroenterology & hepatology.

Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn’s Disease

Steven J Brown, M. Kamm, W. Selby, 2018, Journal of Crohn's & colitis.

Erratum: Characterization of Inflammatory Bowel Disease With Urinary Metabolic Profiling

Subrata Ghosh, D. Jewell, S. Taylor-Robinson, 2009, The American Journal of Gastroenterology.

Inflammatory Bowel Disease Clinical

M. Appleyard, P. Bampton, G. Radford-Smith, 2016, Journal of gastroenterology and hepatology.

Management of acute severe colitis.

S. Travis, S. Jakobovits, Simon Travis, 2005, British medical bulletin.

Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006

S. Travis, D. Jewell, S. Jakobovits, 2007, Alimentary pharmacology & therapeutics.

Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.

Steven J Brown, M. Kamm, W. Selby, 2015, Gastroenterology.

Adalimumab prevents post-operative Crohn's disease recurrence, and is superior to thiopurines: early results from the POCER study

Steven J Brown, M. Kamm, J. Andrews, 2012 .

1161 Adalimumab Prevents Post-Operative Crohn's Disease Recurrence, and is Superior to Thiopurines: Early Results From the POCER Study

Steven J Brown, M. Kamm, W. Selby, 2012 .

Su2092 Clinical Risk Stratification Predicts Development of Endoscopic Recurrence After Crohn's Disease Surgery: Early Results From the POCER Study

Steven J Brown, M. Kamm, W. Selby, 2012 .

P342 Adalimumab prevents post-operative Crohn's disease recurrence and is superior to thiopurines: E

Steven J Brown, W. Selby, J. Andrews, 2012 .

Buprenorphine-associated gastroparesis during in-patient heroin detoxification.

Robert Y Chen, S. Jakobovits, M. McDonough, 2007, Addiction.